Results of Iliac Artery Stent Placement in Patients Younger than 50 Years of Age

Long-term Cardiovascular Morbidity, Mortality, and Reintervention after Endovascular Treatment in Patients with Iliac Artery Disease: The Dutch Iliac Stent Trial Study

“…This means that when stent placement, which is frequently considered easier and faster to perform than PTA followed by pressure measurement (which still leads to stent placement in 43% of patients, as found in the DIST study [13]), is used more liberally it does not seem to harm the patient either. The number of iliac reinterventions performed in this study after more than 5 years (18% in group 1 and 20% in group 2) seems to be well in line with the results of other studies (5,8,9,11,25,(27)(28)(29)(30)(31). Schurmann et al (30) retrospectively investigated 110 patients who underwent iliac stent placement and found a 28% rate of reintervention, but this was over a 10-year period.…”

Aortoiliac Kissing Stents:Long-term Results and Analysis of Risk Factors Affecting Patency

“…The authors indicated increased virulence of aortic disease, smaller aortic size, and more progressive infrainguinal disease as the responsible factors. Unlike its negative effect on surgery, younger age has not been found to be a significant risk factor for iliac artery stent placement in the study of Siskin et al 19 These authors reported that at 1, 2, and 3 years, the primary patency rates were 86%, 72%, and 65%, and the secondary patency rates were 90%, 88%, and 88%, respectively; these figures were found comparable to those reported for older patients. In contrast to the results of Siskin et al, 19 in our study, primary and secondary patency rates at 1 to 5 years were 64% to 32% and 86% to 43%, respectively, for kissing-stent patients who were Ͻ50 years of age; these figures were significantly lower than those for patients who were Ͼ50 (log rank 0.002 and 0.003, respectively).…”

Iliac Artery Angioplasty: Technique and Results

“…Hormone replacement therapy has also been shown to be an additional risk factor for long-term failure of iliac stenting (21). Younger age does not influence the longterm success of the percutaneous treatment : in a recent study that included 42 patients with a mean age of 45 years treated with iliac artery stenting, 3-years patency rates were similar to those reported in the general population (22). Overall, very few predictors for patency have been consistently identified in the published literature (8).…”